GLP-1 controls appetite, stimulates glucose-dependent insulin release, suppresses glucagon, and slows gastric emptying, which is why it underpins weight-loss and diabetes drugs
Building that plan into care from the beginning can prevent weight regain, improve long-term health improvements, and reduce ongoing costs
Mounjaro targets multiple pathways, making it potentially more effective for weight management
All of these could be related to understanding sexual behavior and motivation.[ 7 ] Potential Weight Loss and Appetite Regulation Research Preclinical studies have shown that PT-141 may reduce food intake through its MC4R activation mechanism.[ 8 ] This may influence the feeding behavior of research subjects
Please consult the pharmaceutical packaging for a full list of side effects, warnings, interactions, and additional information
In addition, investigators could titrate insulin glargine at their discretion between study visits